Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06435455
What this trial is testing

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation
Suzhou Genhouse Bio Co., Ltd. 126
Early research (Phase 1)Study completedNCT01188785
What this trial is testing

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 15
Very early researchNot Yet RecruitingNCT07182435
What this trial is testing

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 36
Early research (Phase 1)Study completedNCT02884726
What this trial is testing

Phase 1 Study of Mesothelin-ADC

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 8
Early research (Phase 1)Not Yet RecruitingNCT06752447
What this trial is testing

A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors (Phase 1)
Shandong New Time Pharmaceutical Co., LTD 94
Early research (Phase 1)Study completedNCT01922752
What this trial is testing

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 32
Early research (Phase 1)Looking for participantsNCT07186452
What this trial is testing

Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hansoh BioMedical R&D Company 18
Early research (Phase 1)WithdrawnNCT02048943
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
Roswell Park Cancer Institute
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Early research (Phase 1)Study completedNCT01645215
What this trial is testing

Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Hutchison Medipharma Limited 40
Early research (Phase 1)WithdrawnNCT05231733
What this trial is testing

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Who this might be right for
Solid Tumors
SparX Biotech(Jiangsu) Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT07669415
What this trial is testing

LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 108
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Early research (Phase 1)Study completedNCT03654547
What this trial is testing

Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer

Who this might be right for
Advanced Solid TumorsTriple Negative Breast Cancer
TransThera Sciences (Nanjing), Inc. 48
Early research (Phase 1)Study completedNCT01940133
What this trial is testing

Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

Who this might be right for
Advanced Solid Tumors
PIQUR Therapeutics AG 28
Early research (Phase 1)UnknownNCT05673538
What this trial is testing

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
TransThera Sciences (Nanjing), Inc. 40
Early research (Phase 1)Looking for participantsNCT07539285
What this trial is testing

HDM2024 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 63
Early research (Phase 1)Study completedNCT05287399
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Ascletis Pharmaceuticals Co., Ltd. 18
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715281
What this trial is testing

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Who this might be right for
Advanced Rare Malignant Solid NeoplasmRare Malignant Solid NeoplasmRefractory Rare Malignant Solid Neoplasm
National Cancer Institute (NCI) 12
Next Page